Supernus Pharmaceuticals reported $4.53M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Abbott USD 71M 11M Jun/2025
Aurora Cannabis CAD 1.97M 633K Jun/2025
Canopy Growth CAD 1.06M 884K Jun/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Eisai 3.11B 783M Mar/2024
Eli Lilly USD 40M 8.3M Jun/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 156M 13M Jun/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Xeris Pharmaceuticals USD 948K 38K Jun/2025